BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:Europe/Helsinki X-WR-TIMEZONE:Europe/Helsinki BEGIN:VEVENT UID:275@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20231024T000000 DTEND;TZID=Europe/Helsinki:20231025T000000 DTSTAMP:20230906T142531Z URL:https://inflames.utu.fi/events/school-of-nanomedicine-and-cancer-immun otherapy/ SUMMARY:School of nanomedicine and cancer immunotherapy DESCRIPTION:Melomanes Fall School\nWe are happy to announce our School of nanomedicine and cancer immunotherapy. It will take place on Tuesday 24th and Wednesday 25th October 2023\, at Åbo Akademi University in Turku ( Finland).\n\nOur Melomanes researchers\, together with invited local part ners\, will provide an overview of their multidisciplinary cutting-edge re search. Discover how nanomedicine and novel immunotherapies are opening ne w roads for cancer treatments!\n\nThis event is aimed at early-stage rese archers interested in getting a broad overview of these fields of researc h.\nIt is open to researchers outside Melomanes network.\n\nInformation a bout registration\, including registration fees\, will be provided by Sept ember 2023 on the website School of nanomedicine and cancer immunotherapy. \nSpeakers\n(Provisional talk titles)\n\n Dr. Yassen Abbas\, CN Bio (Unit ed Kingdom): Development of organ-on-chip for the investigation of cancer treatments\n Prof. Khuloud Al-Jamal\, King’s College London (United Ki ngdom): Therapeutic and diagnosis applications of nanomaterials\n Dr. Be lén Ballesteros\, Institut Català de Nanociència i Nanotecnologia (Spai n): Advanced electron microscopy techniques for nanoscience\n Prof. Davi de Bonifazi\, University of Vienna (Austria): Functional organic architec tures for nanomedicine\n Dr. Emmanuel Donnadieu\, Institut Cochin (France ): Targeting the tumor microenvironment to improve T cell-based immunothe rapies\n Dr. Lorena García Hevia\, IDIVAL (Spain): Nanomaterials for ca ncer treatments\n Dr. Florence Gazeau\, CNRS MSC Med (France): Magnetic hyperthermia and photothermal treatments in nanomedicine\n Prof. Roland G rafström\, Misvik (Finland): Assessment of cellular mode-of-actions by t oxicogenomics space modeling\n Dr. Roland Hischier\, Empa (Switzerland):  Life cycle assessment in nanomedicine\n Dr. Jianwei Li\, University of Turku (Finland): Molecular systems engineering for nanomedicine\n Dr. C écilia Ménard-Moyon\, CNRS I2CT (France): Multifunctionalisation of nan oparticles for nanomedicine\n Dr. Michiel van Oudheusden\, Vrije Universi teit Amsterdam (Netherlands): Responsible modulation of nanotechnology\n Prof. Jessica Rosenholm\, Åbo Akademi University (Finland): Multifuncti onal hybrid and composite nanostructures for drug delivery and imaging\n Dr. Gerard Tobias\, Institut Català de Nanociència i Nanotecnologia (Spa in): Radioactive nanomaterials for the diagnosis and treatment of cancer\ n Prof. Sébastien Wälchli\, Oslo University Hospital (Norway): New per spectives of engineered T-cells in cancer therapy\n\n Prof. Hongbo Zhang\ , Åbo Akademi University (Finland): Functional materials for biomedical applications and clinical translation\n to be confirmed\, Orion (Finland) : AI-powered drug delivery development\n\n \;\nAbout Melanomanes\nMEL ANOMANES has received funding from the European Union’s Horizon Europe r esearch and innovation programme under the Marie Skłodowska-Curie grant. MELOMANES aims to train 12 doctoral researchers for the development of a c ombined therapy exploiting the properties of magnetic nanoparticles to ind uce damage on the tumor microenvironment by magnetic and optic hyperthermi a in order to facilitate the infiltration of CAR-T cells. ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/Logo- Melomanes-Favicon.png LOCATION:https://melomanes.eu/school-of-nanomedicine-and-immunotherapy-turk u-24th-25th-october-2023/ END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:DAYLIGHT DTSTART:20230326T040000 TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST END:DAYLIGHT END:VTIMEZONE END:VCALENDAR